Placental, fetal, and neonatal carbohydrate metabolism

W. W. Hay, John W Sparks

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Glucose metabolism in the placenta and fetus is characterized by a fairly exact balance between exogenous glucose supply from the mother and placental and fetal glucose utilization (directly and as lactate produced from glucose). The rate of glucose utilization and its rate of oxidation are largely determined by the maternal glucose concentration and are mediated in part by insulin. Thus, glucose and insulin act together to substitute glucose oxidation for the oxidation of other energy substrates and to direct glucose carbon into glycogen, fat, and protein accretion. After birth, endogenous glucose production and dietary glucose intake (as glucose or as galactose) must account for the maintenance of glucose supply. In many cases, however, the balance among glucose intake, glucose production, and glucose utilization is inexact in the transition from intrauterine to extrauterine life, leading to both hypoglycemia and hyperglycemia. Basic measurements of the glucose production rate and the glucose utilization rate can be made now in the fetus as well as in the neonate, but the factors producing perturbations in glucose supply and utilization and in regulating the responses to these perturbations remain to be measured.

Original languageEnglish (US)
Pages (from-to)473-485
Number of pages13
JournalClinical obstetrics and gynecology
Volume28
Issue number3
DOIs
StatePublished - Jan 1 1985

Fingerprint

Carbohydrate Metabolism
Glucose
Fetus
Insulin

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Placental, fetal, and neonatal carbohydrate metabolism. / Hay, W. W.; Sparks, John W.

In: Clinical obstetrics and gynecology, Vol. 28, No. 3, 01.01.1985, p. 473-485.

Research output: Contribution to journalArticle

@article{989f351a131046f28fbea6c21528d181,
title = "Placental, fetal, and neonatal carbohydrate metabolism",
abstract = "Glucose metabolism in the placenta and fetus is characterized by a fairly exact balance between exogenous glucose supply from the mother and placental and fetal glucose utilization (directly and as lactate produced from glucose). The rate of glucose utilization and its rate of oxidation are largely determined by the maternal glucose concentration and are mediated in part by insulin. Thus, glucose and insulin act together to substitute glucose oxidation for the oxidation of other energy substrates and to direct glucose carbon into glycogen, fat, and protein accretion. After birth, endogenous glucose production and dietary glucose intake (as glucose or as galactose) must account for the maintenance of glucose supply. In many cases, however, the balance among glucose intake, glucose production, and glucose utilization is inexact in the transition from intrauterine to extrauterine life, leading to both hypoglycemia and hyperglycemia. Basic measurements of the glucose production rate and the glucose utilization rate can be made now in the fetus as well as in the neonate, but the factors producing perturbations in glucose supply and utilization and in regulating the responses to these perturbations remain to be measured.",
author = "Hay, {W. W.} and Sparks, {John W}",
year = "1985",
month = "1",
day = "1",
doi = "10.1097/00003081-198528030-00003",
language = "English (US)",
volume = "28",
pages = "473--485",
journal = "Clinical Obstetrics and Gynecology",
issn = "0009-9201",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Placental, fetal, and neonatal carbohydrate metabolism

AU - Hay, W. W.

AU - Sparks, John W

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Glucose metabolism in the placenta and fetus is characterized by a fairly exact balance between exogenous glucose supply from the mother and placental and fetal glucose utilization (directly and as lactate produced from glucose). The rate of glucose utilization and its rate of oxidation are largely determined by the maternal glucose concentration and are mediated in part by insulin. Thus, glucose and insulin act together to substitute glucose oxidation for the oxidation of other energy substrates and to direct glucose carbon into glycogen, fat, and protein accretion. After birth, endogenous glucose production and dietary glucose intake (as glucose or as galactose) must account for the maintenance of glucose supply. In many cases, however, the balance among glucose intake, glucose production, and glucose utilization is inexact in the transition from intrauterine to extrauterine life, leading to both hypoglycemia and hyperglycemia. Basic measurements of the glucose production rate and the glucose utilization rate can be made now in the fetus as well as in the neonate, but the factors producing perturbations in glucose supply and utilization and in regulating the responses to these perturbations remain to be measured.

AB - Glucose metabolism in the placenta and fetus is characterized by a fairly exact balance between exogenous glucose supply from the mother and placental and fetal glucose utilization (directly and as lactate produced from glucose). The rate of glucose utilization and its rate of oxidation are largely determined by the maternal glucose concentration and are mediated in part by insulin. Thus, glucose and insulin act together to substitute glucose oxidation for the oxidation of other energy substrates and to direct glucose carbon into glycogen, fat, and protein accretion. After birth, endogenous glucose production and dietary glucose intake (as glucose or as galactose) must account for the maintenance of glucose supply. In many cases, however, the balance among glucose intake, glucose production, and glucose utilization is inexact in the transition from intrauterine to extrauterine life, leading to both hypoglycemia and hyperglycemia. Basic measurements of the glucose production rate and the glucose utilization rate can be made now in the fetus as well as in the neonate, but the factors producing perturbations in glucose supply and utilization and in regulating the responses to these perturbations remain to be measured.

UR - http://www.scopus.com/inward/record.url?scp=0022360238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022360238&partnerID=8YFLogxK

U2 - 10.1097/00003081-198528030-00003

DO - 10.1097/00003081-198528030-00003

M3 - Article

VL - 28

SP - 473

EP - 485

JO - Clinical Obstetrics and Gynecology

JF - Clinical Obstetrics and Gynecology

SN - 0009-9201

IS - 3

ER -